NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 289 filers reported holding NATERA INC in Q1 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,747,444 | +22.8% | 84,688 | +35.1% | 0.24% | +22.6% |
| Q2 2023 | $3,050,447 | -11.7% | 62,689 | +0.7% | 0.20% | -3.9% |
| Q1 2023 | $3,455,232 | +134.5% | 62,234 | +69.7% | 0.21% | +168.8% |
| Q4 2022 | $1,473,315 | +82.8% | 36,677 | +99.4% | 0.08% | +165.5% |
| Q3 2022 | $806,000 | -67.4% | 18,394 | -30.6% | 0.03% | -54.0% |
| Q4 2021 | $2,476,000 | -24.0% | 26,513 | -9.3% | 0.06% | -24.1% |
| Q3 2021 | $3,258,000 | +0.9% | 29,235 | +2.8% | 0.08% | -13.5% |
| Q2 2021 | $3,230,000 | +10.2% | 28,450 | -1.5% | 0.10% | +28.0% |
| Q1 2021 | $2,932,000 | +707.7% | 28,880 | +691.0% | 0.08% | +733.3% |
| Q4 2020 | $363,000 | +4.6% | 3,651 | -23.9% | 0.01% | -47.1% |
| Q3 2020 | $347,000 | +11466.7% | 4,800 | +5117.4% | 0.02% | – |
| Q4 2019 | $3,000 | -99.6% | 92 | -99.7% | 0.00% | -100.0% |
| Q1 2019 | $679,000 | +96.8% | 32,908 | +33.2% | 0.04% | +65.2% |
| Q4 2018 | $345,000 | -80.6% | 24,704 | -66.7% | 0.02% | -77.7% |
| Q3 2018 | $1,775,000 | +9.2% | 74,136 | -14.2% | 0.10% | 0.0% |
| Q2 2018 | $1,625,000 | -1.0% | 86,364 | -51.3% | 0.10% | -13.4% |
| Q1 2018 | $1,642,000 | +73.8% | 177,174 | +68.5% | 0.12% | +56.6% |
| Q4 2017 | $945,000 | -39.4% | 105,150 | -13.1% | 0.08% | -46.1% |
| Q3 2017 | $1,560,000 | +320.5% | 121,003 | +254.6% | 0.14% | +302.9% |
| Q2 2017 | $371,000 | +12.1% | 34,121 | +20.6% | 0.04% | -12.5% |
| Q4 2016 | $331,000 | +2909.1% | 28,296 | +2729.6% | 0.04% | +3900.0% |
| Q3 2016 | $11,000 | +83.3% | 1,000 | +66.7% | 0.00% | 0.0% |
| Q1 2016 | $6,000 | -25.0% | 600 | -14.3% | 0.00% | 0.0% |
| Q4 2015 | $8,000 | – | 700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |